UID:
almahu_9948026707102882
Umfang:
1 online resource (801 p.)
ISBN:
1-281-00356-5
,
9786611003562
,
0-08-047501-9
Inhalt:
Toxoplasmosis is caused by a one-celled protozoan parasite known as Toxoplasma gondii. In the United States, it is estimated that approximately 30% of cats, the primary carriers, have been infected by T. gondii. Most humans contract toxoplasmosis by eating cyst-contaminated raw or undercooked meat, vegetables, or milk products or when they come into contact with the T. gondii eggs from cat feaces while cleaning a cat's litterbox, gardening, or playing in a sandbox. Approx 1 in 4 (more than 60 million) people in the USA are infected with the parasite, and in the UK between
Anmerkung:
Description based upon print version of record.
,
Front cover; Toxoplasma gondii; Copyright page; Contents; Contributors; Preface; Acknowledgements; Chapter 1: The History and Life Cycle of Toxoplasma gondii; 1.1 INTRODUCTION; 1.2 THE ETIOLOGICAL AGENT; 1.3 PARASITE MORPHOLOGY AND LIFE CYCLE; 1.4 TRANSMISSION; 1.5 TOXOPLASMOSIS IN HUMANS; 1.6 TOXOPLASMOSIS IN OTHER ANIMALS; 1.7 DIAGNOSIS; 1.8 TREATMENT; 1.9 PREVENTION AND CONTROL; ACKNOWLEDGEMENTS; REFERENCES; Chapter 2: The Ultrastructure of Toxoplasma gondii; 2.1 INTRODUCTION; 2.2 INVASIVE STAGE ULTRASTRUCTURE AND GENESIS; 2.3 COCCIDIAN DEVELOPMENT IN THE DEFINITIVE HOST
,
2.4 DEVELOPMENT IN THE INTERMEDIATE HOSTREFERENCES; Chapter 3: Population Structure and Epidemiology of Toxoplasma gondii; 3.1 INTRODUCTION; 3.2 MARKERS FOR GENETIC STUDIES; 3.3 PARASITE POPULATION GENETICS; 3.4 FACTORS AFFECTING TRANSMISSION AND GENETIC EXCHANGE; 3.5 MOLECULAR EPIDEMIOLOGICAL STUDIES; 3.6 TOXOPLASMA GENOTYPE AND BIOLOGICAL CHARACTERISTICS; 3.7 TOXOPLASMA GENOTYPE AND HUMAN DISEASE; 3.8 CONCLUSIONS; ACKNOWLEDGEMENTS; REFERENCES; Chapter 4: Clinical Disease and Diagnostics; 4.1 INTRODUCTION; 4.2 CLINICAL DISEASE
,
4.3 DIAGNOSIS OF INFECTION WITH TOXOPLASMA GONDII IN THE HUMAN HOST4.4 TREATMENT OF TOXOPLASMOSIS; REFERENCES; Chapter 5: Ocular Disease Due to Toxoplasma gondii; 5.1 INTRODUCTION; 5.2 HISTORICAL FEATURES OF OCULAR TOXOPLASMOSIS; 5.3 EPIDEMIOLOGY; 5.4 THE MECHANISM OF TISSUE DAMAGE IN OCULAR TOXOPLASMOSIS; 5.5 HOST FACTORS IN OCULAR TOXOPLASMOSIS; 5.6 PARASITE FACTORS IN OCULAR INFECTION; 5.7 ANIMAL MODELS; 5.8 CLINICAL CHARACTERISTICS; 5.9 DIAGNOSTIC TESTS AND PATHOLOGY; 5.10 THE TREATMENT AND MANAGEMENT OF OCULAR TOXOPLASMOSIS; ACKNOWLEDGEMENTS; REFERENCES
,
Chapter 6: Toxoplasmosis in Wild and Domestic Animals6.1 INTRODUCTION; 6.2 TOXOPLASMOSIS IN WILDLIFE; 6.3 TOXOPLASMOSIS IN ZOOS; 6.4 TOXOPLASMA GONDII AND ENDANGERED SPECIES; 6.5 TOXOPLASMOSIS IN PETS; 6.6 DOMESTIC FARM ANIMALS; 6.7 FISH, REPTILES, AND AMPHIBIANS; REFERENCES; Chapter 7: Toxoplasma Animal Models and Therapeutics; 7.1 INTRODUCTION; 7.2 CONGENITAL TOXOPLASMOSIS; 7.3 OCULAR TOXOPLASMOSIS; 7.4 CEREBRAL TOXOPLASMOSIS; REFERENCES; Chapter 8: Biochemistry and Metabolism of Toxoplasma gondii; 8.1 INTRODUCTION; 8.2 CARBOHYDRATE METABOLISM; 8.3 GLYCOLIPID ANCHORS
,
8.4 NUCLEOTIDE BIOSYNTHESIS8.5 NUCLEOSIDE TRIPHOSPHATE HYDROLASE (NTPase); REFERENCES; Chapter 9: The Apicoplast and Mitochondrion of Toxoplasma gondii; 9.1 INTRODUCTION; 9.2 THE APICOPLAST; 9.3 THE MITOCHONDRION; 9.4 PERSPECTIVES; ACKNOWLEDGEMENTS; REFERENCES; Chapter 10: Calcium Storage and Homeostasis in Toxoplasma gondii; 10.1 INTRODUCTION; 10.2 FLUORESCENCE METHODS TO STUDY CALCIUM HOMEOSTASIS IN T. GONDII; 10.3 REGULATION OF [Ca2+]i IN T. GONDII; 10.4 CALCIUM STORAGE; 10.5 Ca2+ FUNCTION IN GONDII; 10.6 CONCLUSIONS; ACKNOWLEDGEMENTS; REFERENCES
,
Chapter 11: Toxoplasma Secretory Proteins and their Roles in Cell Invasion and Intracellular Survival
,
English
Weitere Ausg.:
ISBN 0-12-369542-2
Sprache:
Englisch
Bookmarklink
